Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > NVAX Novavax > Detailed Quotes

NVAX Novavax

21.0000.0000.00%
Close 09/26 09:30 ET
20.800
-0.200-0.95%
Pre Mkt Price 09/26 09:25 ET
High
0.000
Open
0.000
Turnover
0.00
Low
0.000
Pre Close
21.000
Volume
0.00
Market Cap
1.64B
P/E(TTM)
Loss
52wk High
236.500
Shares
78.22M
P/E(Static)
Loss
52wk Low
20.460
Float Cap
1.64B
Bid/Ask %
71.43%
Historical High
331.680
Shs Float
77.91M
Volume Ratio
0.98
Historical Low
3.540
Dividend TTM
--
Div Yield TTM
--
P/B
-3.94
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
Lot Size
1
Float Cap
1.64B
Bid/Ask %
71.43%
Historical High
331.680
Shs Float
77.91M
Volume Ratio
0.98
Historical Low
3.540
Dividend TTM
--
P/B
-3.94
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
CEO: Mr. Stanley Charles Erck
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...